1 / 96

OPIATES

Psych 181: Dr. Anagnostaras Lecture 8. OPIATES. Opioids. Opiates alkaloids found in the opium poppy (Papaver somniferum) [Gk. opion = “poppy juice”] Opioids compounds with opiate-like actions, including, but not confined to opiates (e.g., synthetic, endogenous opioids). Types of opioids.

manju
Download Presentation

OPIATES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Psych 181: Dr. Anagnostaras Lecture 8 OPIATES

  2. Opioids Opiates • alkaloids found in the opium poppy (Papaver somniferum) • [Gk. opion = “poppy juice”] Opioids • compounds with opiate-like actions, including, but not confined to opiates (e.g., synthetic, endogenous opioids)

  3. Types of opioids 1. Naturally-occurring • opium • sap fromopium poppy Two major activealkaloids • morphine • codeine

  4. Morphine • Morpheus (god of Dreams) -son of Hypnos • ~ 10% of opiumby weight

  5. Codeine • methylmorphine • ~ 0.5% ofopium

  6. 2. Semi-synthetics

  7. 2. Semi-synthetics Heroin • diacetylmorphine • addition of two acetyl groups to morphine • ~ 10x more potent than morphine • pharmacological effect usually thought to be identical to morphine • in brain: heroin > morphine(new data suggest morphine and heroinmay have different actions; 1999)

  8. Semi-synthetic analgesics • Hydromorphone (Dilaudid®) • Hydrocodone (Hycodan®, Vicodin®) • Oxycodone (Percodan®, Oxycontin®)

  9. 3. Synthetics Phenylpiperidines • Fentanyl “china white” • Carfentanil (Wildnil®) • Meperidine (Demerol®) (MPPP) Methadone & Congeners • Methadone (Dolophine®) • Propoxyphene (Darvon®) Benzomorphans • Pentazocine (Talwin®)

  10. Analgesic potency Analgesic potency Mild to moderate pain codeine, propoxyphene (Darvon®) Moderately severe pain meperdine (Demerol®) Severe pain heroin, hydromorphone (Dilaudid®)

  11. "Perc-a-pop"

  12. 4. Opioid antagonists • naloxone (Narcan®) • naltrexone • Suboxone® (buprenorphine + naloxone)

  13. 5. Endogenous opioids • Enkephalins, endorphins and dynorphins • Morphine & codeine?

  14. History of use - opium Since recorded history Ingredient in all sorts of medicinal preparations

  15. History of use - morphine “Soldiers disease”

  16. History of use Ads for heroin

  17. Major effects Analgesia • Relief of pain in absence of impairment in other sensory modalities Euphoria - Pleasure • Produce sense of well being, reduce anxiety, positive feelings

  18. Other effects • Nausea & vomiting • Respiratory depression • Miosis (opposite of mydriasis) • Gastrointestinal effects • Cough Suppression • Motor effects

  19. Effects of repeated administration Tolerance, withdrawal & sensitization

  20. Tolerance and withdrawal LC unit activity Behavioral withdrawal score Time (hr) 12.18

  21. Sensitization • Psychomotor stimulant effects • Rewarding effects (conditioned place preference)

  22. Mechanisms of action • Primary action on opioid receptors located in CNS +/or periphery Different effects due to action at • Different receptor subtypes • Receptors in different locations

  23. Endogenous opioids Translation Post-translational processing 11.4

  24. Opioid peptide gene families Three different gene families • Proopiomelanocortin (POMC) • Proenkephalin • Prodynorphin (‘proenkephalin B’) 12.5

  25. Precursor gene families Proopiomelanocortin (POMC) • ß-endorphin • ACTH, melanocortin SH Proenkephalin -> Enkephalins • met-enkephalin & 2 extended met-enk • leu-enkephalin • Prodynorphine - forms of leu-enkephalin • Dynorphins, A and B • Neoendorphins, µ and 

  26. Differential distribution Endorphins • discrete • hypothalamic - endocrine related Enkephalins and Dynorphins • wide distribution, local circuit and short axon projections

  27. Opioid receptors

  28. Opioid receptors SubtypePreferred Ligand Mu (µ) Morphine & endorphins Delta () Enkephalins Kappa () Ketocyclazocine & dynorphins • Each subtype has subtypes

  29. Opioid receptors   

  30. Cellular actions • G protein coupled receptors • inhibitory Negatively-coupled 12.4

  31. Role in drug action

  32. Analgesia • Spinal actions • Dorsal horn of spinal cord • primary pain afferents 4.2

  33. Analgesia Spinal actions • inhibit incoming pain signals Opioid receptor 12.8

  34. Analgesia Supraspinal actions 12.10

  35. Analgesia Supraspinal actions Stimulation > analgesia andinhibit cells in dorsal horn 12.10

  36. Analgesia Supraspinal actions Lesion > block analgesiato systemic or local morphine 12.10

  37. Analgesia Supraspinal actions • µ1 sites seem most important • Specific blockade of µ1 shifts dose-response curve for morphine analgesia up to 12 fold to right

  38. Analgesia Heroin vs. Morphine • difference pharmacokinetic? • recent evidence for different receptors - MOR-1 knockouts

  39. Analgesia - MOR1 knockouts Schuller et al., Nature Neurosci. (1999) Morphine, but not heroin, analgesiaabolished in Mor1 knockout mice Analgesia (%) heroin > 6-acetyl-morphine in vivo

  40. Reinforcing effects

  41. Reinforcing effects • All classical opioid drugs of abuse have a preference for µ sites (e.g., morphine, heroin, methadone, fentanyl etc.) •  may contribute, but little known •  compounds are not self-administered • psychomimetic and aversive in humans

  42. Opioid/DA interaction • Intra-VTA opioid support SA and CPP • DA antagonist or 6-OHDA lesion impair SA • DA antagonist into VTA or ACC impair SA

  43. Mechanism µ compounds: • Increase DA cell firing • Increase DA release in ACC • Accompanied by locomotor activation

  44. Model for reinforcing effects Site of action • VTA – accumbens DA system “Disinhibition”  12.16

More Related